This consultation continues a process begun in Seattle in October 2011. It will provide an opportunity to discuss past experience with large-scale interventions to expand RDT use, in both the public and the (formal and informal) private sectors and in urban and rural settings. Additionally trajectories for expansion in countries where RDT use remains low will be discussed, focusing on questions such as whether the initial focus should be on the formal sectors (public and private) where there is greater likelihood of success, or on the informal sector where antimalarial use is greatest and where the potential for reducing deaths and for decreasing inappropriate use of both antibiotics and antimalarials is also the greatest. RDT/ACT bundling at different levels of subsidy will also be discussed. A third set of issues relates to the trajectories for expanding RDT use in a world where there is ongoing financing for antimalarials but declining global health resources. Finally, with advice from participants, an agenda will be established for the following 18 months of analytical work and consultations to better define how best to finance and treat febrile illness in a world with possibly less malaria and certainly fewer resources.